8-KThe WireRoutine
Company Update
Filed Oct 20, 2022 · 3y ago · Accession 0001564590-22-034773
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Oruka Therapeutics, Inc.
- Ticker
- ORKA
- CIK
- 907654
- Form type
- 8-K
- Filing date
- Oct 20, 2022
- Report date
- Oct 20, 2022
- Document
- abio-8k_20221020.htm
- Size
- 160 KB